Navigation Links
Researchers identify breast cancer culprits
Date:8/17/2010

Scientists have discovered an accomplice in breast cancer a master control switch with the power to set off a cascade of reactions orchestrated by a cancer-causing gene (or oncogene) named Wnt1. This executive molecule and its modus operandi are reported in back-to-back papers featured on the cover of the August 15 issue of Cancer Research.

"These papers are about the regulation of a Wnt oncogene," explains lead author Rakesh Kumar, Ph.D., professor and the Catharine Birch & William McCormick Chair of the department of biochemistry and molecular biology at The George Washington University School of Medicine and Health Sciences. Now, Kumar and his team describe how a master switch sparks a type of Wnt signaling in breast cancer. Moreover, this master control switch may help explain why increased levels of a protein called MTA1 (metastasis-associated protein 1) are oncogenic in certain types of breast cancer.

Like many molecular pathways underlying cancer, Wnt pathways govern normal processes like embryonic development and the communication between cells in healthy people. For reasons little understood, however, certain types of Wnt proteins sometimes go awry, sending off cascades of signals that turn normal cells into cancerous ones. Researchers often find evidence of Wnt pathway activation when they analyze what genes are turned on in tumors. Although Wnt has been connected with breast cancer for nearly 30 years, however, the signals (other than mutations) that trigger it remain largely unknown.

Kumar and his team have implicated MTA1 and a shorter variation of the protein, MTA1s, in Wnt1 (a type of Wnt) pathway activation. MTA1 belongs to the MTA family of genes, which help a range of cancers progress in a variety of ways. Before this study, researchers knew that MTA1 levels were higher than normal in breast, ovarian, prostate, colorectal, gastric, liver tumors, and more. But they still didn't know everything about what MTA's were doing there.

In the current studies, funded by a grant from the National Cancer Institute, Kumar's team finds that MTA1 expression triggers cancer-causing signals from Wnt1 in human breast cancer cells. This Wnt1 signaling cascade leads to tumors, they demonstrate, by showing that 8.8 percent of mice bearing artificially elevated levels of MTA1s grew tumors in their mammary glands.

To get down to the details, Kumar and his fellow researchers show that MTA1 and MTA1s activate the cancer-causing pathway by reducing the levels of a protein known as Six3. This protein is known to inhibit Wnt1 in brain cells, but in their study involving breast cancer cells, it inhibited Wnt1 in a rather non-intuitive way. Six3 normally puts the brakes on Wnt signaling, and so when MTA1 obstructed Six3, Wnt1 signals let loose. In addition, the team found that MTA1s also promoted Wnt signaling directly and through another known Wnt-related pathway namely ERK-mediated GSK3.

Because inflammation may drive MTA1, and since inflammation is believed to drive certain forms of cancer, Kumar's work suggests one possible reason for why worsening cancer progression has been correlated with other inflammation-inducers. "We've raised the next level question," says Kumar, "and now we're going back into the lab to ask if this pathway plays a role in inflammation-related cancer."


'/>"/>

Contact: Anne Banner
mcmacb@gwumc.edu
202-994-2261
George Washington University Medical Center
Source:Eurekalert

Related medicine news :

1. Gulf Oil Spill Still a Health Threat to Many, Researchers Report
2. Researchers identify potential new target for ovarian cancer
3. Amphetamine use increases risk of aortic tears in young adults, UT Southwestern researchers report
4. Researchers find function of proteins that can enhance the progression of viruses and cancer cells
5. In NIH-funded study, researchers uncover step in brain events leading up to addiction
6. Researchers develop magnetic molecular machines to deliver drugs to unhealthy cells
7. UCLA researchers discover protein that shuttles RNA into cell mitochondria
8. Help wanted: Highly cited researchers needed for high-ranking positions at research institutions
9. NIST researchers measure high infrared power levels from some green lasers
10. Mayo Clinic researchers share latest findings in CT radiation dose reduction efforts
11. Researchers develop advanced search tool to help physicians sort and retrieve vital EMR data
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:10/13/2017)... ... ... While it’s often important to take certain medications during the night, finding ... identified a solution. , She developed a prototype for MOTION LIGHT-UP PILL BOX to ... the need to turn on a light when taking medication during the night, allowing ...
(Date:10/13/2017)... ... October 13, 2017 , ... Lori R. Somekh, founder of the ... a national organization of elder law and special needs planning attorneys. “Membership in ElderCounsel ... also provides a forum to network with elder law attorneys nationwide,” said Somekh. ...
(Date:10/13/2017)... ... 2017 , ... Global Healthcare Management’s 4th Annual Kids Fun Run brought out ... free event, sponsored by Global Healthcare Management’s CEO, Jon Letko, is aimed at getting ... children of all ages; it is a non-competitive, non-timed event, which is all about ...
(Date:10/13/2017)... ... ... On The Brink”: the Christian history of the United States and the loss of ... William Nowers. Captain Nowers and his wife, Millie, have six children, ten grandchildren, ... Navy. Following his career as a naval aviator and carrier pilot, he spent ...
(Date:10/12/2017)... ... October 12, 2017 , ... IsoComforter, Inc. ( https://isocomforter.com ... introduction of an innovative new design of the shoulder pad. The shoulder pad ... comfort while controlling your pain while using cold therapy. By utilizing ice and water ...
Breaking Medicine News(10 mins):
(Date:10/2/2017)... COPENHAGEN, Denmark , Oct. 2, 2017 The ... tool in the struggle to reverse the tide of prescription ... plan for regulating their medicine intake and stepping down their ... is set to launch in December 2017; the first 100,000 ... access. Learn more at http://www.rebound-solution.com/ ...
(Date:9/27/2017)... Sept. 27, 2017  DarioHealth Corp. (NASDAQ: DRIO), a leading global digital ... its MyDario product is expected to appear on The Dr. Oz Show ... Oz Show airs in your area: http://www.doctoroz.com/page/where-watch-dr-oz-show ... The nine-time Emmy award-winning, The Dr. Oz Show kicked off ... The segment features ...
(Date:9/22/2017)... , Sept. 22, 2017  As the latest ... Senators Bill Cassidy (R-LA) and Lindsey ... notes that the medical device industry is in an ... device tax, the 2.3% excise tax on medical device ... they also want covered patients, increased visits and hospital ...
Breaking Medicine Technology: